Clincosm LogoSign in Get a demo

solid tumor, adult

Showing 1 - 25 of 199
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumor, Adult Trial in China (GT201)

Recruiting
  • Solid Tumor, Adult
  • Beijing, Beijing, China
  • +3 more
Nov 17, 2023

Solid Tumor, Adult Trial in Providence, Nashville (DF6215)

Not yet recruiting
  • Solid Tumor, Adult
  • Providence, Rhode Island
  • +1 more
Oct 25, 2023

Refractory Cancer, CNS Tumors, CNS Tumor, Adult Trial in Atlanta, New York (Avutometinib)

Recruiting
  • Refractory Cancer
  • +14 more
  • Atlanta, Georgia
  • +1 more
Oct 23, 2023

Solid Tumor, Adult, Refractory Tumor Trial in Dallas, San Antonio (DCR-STAT3)

Recruiting
  • Solid Tumor, Adult
  • Refractory Tumor
  • Dallas, Texas
  • +1 more
Oct 21, 2023

Molecular Services and EMR-Lab Integration Application for

Not yet recruiting
  • Advanced Cancer
  • +2 more
  • Comprehensive Genomic Profile testing; ELIA software; Molecular Genetic Pathologist consultation
  • limited genetic testing or no testing
  • Rock Hill, South Carolina
    Carolina Blood and Cancer Care Associates
Oct 18, 2023

Solid Tumor, Adult Trial in Beijing, Shanxi, Shenzhen (ABO2011 Injection)

Recruiting
  • Solid Tumor, Adult
  • ABO2011 Injection
  • Beijing, China
  • +2 more
Oct 13, 2023

Solid Tumor, Adult, Solid Tumor, Gastric Cancer Trial in Seongnam, Seoul (PB101)

Recruiting
  • Solid Tumor, Adult
  • +5 more
  • Seongnam, Korea, Republic of
  • +2 more
Oct 11, 2023

Solid Tumor, Adult Trial (CF33-CD19 IT, CF33-CD19 IV, Blinatumomab)

Not yet recruiting
  • Solid Tumor, Adult
  • CF33-CD19 IT
  • +2 more
  • (no location specified)
Sep 26, 2023

Solid Tumor, Adult Trial in Boston, Canton, Houston (HB0045 Drug Product)

Not yet recruiting
  • Solid Tumor, Adult
  • HB0045 Drug Product
  • Boston, Massachusetts
  • +2 more
Sep 20, 2023

Solid Tumor, Adult, Colorectal Cancer, NSCLC Trial in United States (A2B694, xT CDx with HLA-LOH Assay)

Not yet recruiting
  • Solid Tumor, Adult
  • +19 more
  • A2B694
  • xT CDx with HLA-LOH Assay
  • Duarte, California
  • +9 more
Sep 22, 2023

Solid Tumor, Adult Trial in Shanghai (Tislelizumab, Lenvatinib, Cryoablation)

Recruiting
  • Solid Tumor, Adult
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Sep 13, 2023

Solid Tumor, Adult Trial (IMSA101, Immune Checkpoint Inhibitor)

Not yet recruiting
  • Solid Tumor, Adult
  • (no location specified)
Sep 6, 2023

Solid Tumor, Adult Trial in Xi'an (Bio-008)

Recruiting
  • Solid Tumor, Adult
  • Bio-008
  • Xi'an, Shaanxi, China
    The First Affiliated Hospital of the Chinese People's Liberation
Aug 30, 2023

Solid Tumor, Adult Trial in Albury (Tiragolumab, Atezolizumab)

Not yet recruiting
  • Solid Tumor, Adult
  • Tiragolumab
  • Atezolizumab
  • Albury, New South Wales, Australia
  • +1 more
Aug 22, 2023

Pathologically Confirmed Cancer Refractory to Conventional Therapy, Refractory Cancer, Metastatic Cancer Trial in Santa Monica

Not yet recruiting
  • Pathologically Confirmed Cancer Refractory to Conventional Therapy
  • +7 more
  • SNK02
  • Santa Monica, California
    Sarcoma Oncology Center
Aug 10, 2023

Solid Tumor, Adult Trial in Beijing (Vaccine)

Not yet recruiting
  • Solid Tumor, Adult
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Aug 3, 2023

Refractory Cancer, Recurrent Cancer, Solid Tumor, Adult Trial in Germany (IMA402 (Phase Ia), IMA402 (Phase Ib), IMA402 (Phase

Not yet recruiting
  • Refractory Cancer
  • +3 more
  • IMA402 (Phase Ia)
  • +2 more
  • Heidelberg, Baden-Wuerttemberg, Germany
  • +12 more
Jul 14, 2023

Solid Tumor, Adult Trial in Beijing (CD70-targeting CAR-T cells)

Recruiting
  • Solid Tumor, Adult
  • CD70-targeting CAR-T cells
  • Beijing, Iotherapeutic Department Of Chinsese PLA Gereral Hospital, China
    China
Jul 8, 2023

Solid Tumor, Adult, Metastasis Trial in West Islip (Palliative and Survivorship Care Model)

Recruiting
  • Solid Tumor, Adult
  • Metastasis
  • Palliative and Survivorship Care Model
  • West Islip, New York
    Good Samaritan University Hospital
Jul 7, 2023

Solid Tumor, Adult Trial in Boston, Canton, Houston (HB0045 Drug Product)

Not yet recruiting
  • Solid Tumor, Adult
  • HB0045 Drug Product
  • Boston, Massachusetts
  • +2 more
Jul 5, 2023

Solid Tumor, Adult, Advanced Solid Tumor, Head Neck Cancer Trial in Irving, San Antonio, West Valley City (SNS-101 (anti-VISTA),

Recruiting
  • Solid Tumor, Adult
  • +19 more
  • Irving, Texas
  • +2 more
May 24, 2023

Solid Tumor, Adult, Advanced Solid Tumor, Advanced Renal Cell Carcinoma Trial in Australia (89Zr-TLX250, 177Lu-TLX250 and

Recruiting
  • Solid Tumor, Adult
  • +2 more
  • 89Zr-TLX250
  • 177Lu-TLX250 and Peposertib
  • North Ryde, New South Wales, Australia
  • +4 more
May 22, 2023

HER2-positive Breast Cancer, Metastatic Cancer, Metastatic Breast Cancer Trial in Chicago, Minneapolis (ALX148, Fam-Trastuzumab

Recruiting
  • HER2-positive Breast Cancer
  • +17 more
  • ALX148
  • Fam-Trastuzumab Deruxtecan-Nxki
  • Chicago, Illinois
  • +1 more
May 19, 2023

Solid Tumor, Adult Trial in Beijing (TY-2699a)

Not yet recruiting
  • Solid Tumor, Adult
  • Beijing, Beijing, China
    National Cancer Center/Cancer Hospital, Chinese Academy of Medic
May 18, 2023

Metastatic Breast Cancer, Advanced Non-Small Cell Squamous Lung Cancer, Solid Tumor, Adult Trial (Patritumab deruxtecan)

Not yet recruiting
  • Metastatic Breast Cancer
  • +2 more
  • Patritumab deruxtecan
  • (no location specified)
May 9, 2023